Laza Medical, the latest Shifamed portfolio company, announced today that it closed a Series A financing worth $36 million.
The latest positive news for a Shifamed company follows multiple milestones over the course of 2023. In June, Shifamed’s Adona Medical unveiled a next-generation heart failure management portfolio. In October, its Akura Medical unit raised $35 million for a thrombectomy system.
Laza Medical develops an imaging solution for cardiac interventions, enabled by AI and state-of-the-art robotics. The Capital Partnership (TCP) led the funding round. GE HealthCare, PA MedTech VC fund, Unorthodox Ventures and Dara holdings all participated.
Los Gatos, California-based Laza plans to use the funds to accelerate product development and further expand its team.
“The closing of this significant financing round validates the large, unmet need Laza’s solution will address, and we are grateful for the strong support of our in…